Literature DB >> 29509600

Perspectives on counseling patients about menopausal hormone therapy: strategies in a complex data environment.

Sharon J Parish1, Rossella E Nappi2,3, Sheryl Kingsberg4.   

Abstract

OBJECTIVE: This narrative review strives to give healthcare providers (HCPs) who care for menopausal women better tools and skills to initiate discussions with women about menopause and hormone therapy (HT), communicate complex concepts and data, and promote shared decision-making.
METHODS: We review relevant studies on HT, barriers to treatment of menopausal symptoms, and effective communication strategies. We also provide recommendations for communicating with patients about HT based on the medical literature and our own professional experience.
RESULTS: Both patient and HCP-related barriers can prevent women from accessing treatment for bothersome symptoms of menopause. Many women and HCPs have a poor understanding of the complex, nuanced data regarding HT. The benefits and risks vary with patient age and time since menopause, duration of use, inclusion of a progestin, and patient medical history. Women may also have fears about potential side effects of HT and feel unable to make informed choices. Strategies for effective patient communication and shared decision-making include use of open-ended questions to elicit patient's concerns and preferences, reflecting back to the patient what the HCP heard, presenting evidence about benefits and risks in language the patient can understand, keeping risks in perspective (eg, provide absolute, and also relative risks) without minimizing them, and making conscious efforts to minimize potential bias.
CONCLUSIONS: Necessary components for achieving high-quality, shared decisions about HT involve a combination of medical evidence, communication skills, and recognition of patient goals and concerns. Use of such strategies can enhance women's satisfaction with care.

Entities:  

Mesh:

Year:  2018        PMID: 29509600     DOI: 10.1097/GME.0000000000001088

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  6 in total

1.  Barriers to surgical menopause counseling in gynecologic cancers: a quantitative and qualitative study of patients and providers.

Authors:  Connor C Wang; Dandi S Huang; Anisa M Carlson; Zhanhai Li; Ahmed Al-Niaimi; Makeba Williams
Journal:  Menopause       Date:  2022-08-01       Impact factor: 3.310

Review 2.  The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review.

Authors:  Maria Uloko; Farah Rahman; Leah Ibrahim Puri; Rachel S Rubin
Journal:  Int J Impot Res       Date:  2022-10-05       Impact factor: 2.408

3.  Sexual functioning in 4,418 postmenopausal women participating in UKCTOCS: a qualitative free-text analysis.

Authors:  Helena Harder; Rachel M L Starkings; Lesley J Fallowfield; Usha Menon; Ian J Jacobs; Valerie A Jenkins
Journal:  Menopause       Date:  2019-10       Impact factor: 2.953

4.  Predictors of Initiating Hormone Replacement Therapy in Postmenopausal Women: A Cross-Sectional Study.

Authors:  Hasan Çilgin
Journal:  ScientificWorldJournal       Date:  2019-01-09

5.  International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.

Authors:  Sharon J Parish; James A Simon; Susan R Davis; Annamaria Giraldi; Irwin Goldstein; Sue W Goldstein; Noel N Kim; Sheryl A Kingsberg; Abraham Morgentaler; Rossella E Nappi; Kwangsung Park; Cynthia A Stuenkel; Abdulmaged M Traish; Linda Vignozzi
Journal:  J Womens Health (Larchmt)       Date:  2021-04-01       Impact factor: 2.681

6.  Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden.

Authors:  Rossella E Nappi; Robin Kroll; Emad Siddiqui; Boyka Stoykova; Carol Rea; Eric Gemmen; Neil M Schultz
Journal:  Menopause       Date:  2021-05-24       Impact factor: 3.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.